Literature DB >> 15605287

Molecular imaging of atherosclerotic plaques with technetium-99m-labelled antisense oligonucleotides.

Guangming Qin1, Yongxue Zhang, Wei Cao, Rui An, Zairong Gao, Guiling Li, Wendai Xu, Kaijun Zhang, Shuren Li.   

Abstract

PURPOSE: The purpose of this study was to visualise experimental atherosclerotic lesions using radiolabelled antisense oligonucleotides (ASONs).
METHODS: Atherosclerosis was induced in New Zealand White rabbits fed 1% cholesterol for approximately 60 days. In vivo and ex vivo imaging was performed in atherosclerotic rabbits and normal control rabbits after i.v. injection of 92.5+/-18.5 MBq (99m)Tc-labelled ASON or (99m)Tc-labelled sense oligonucleotides. Immediately after the in vivo imaging, the animals were sacrificed and ex vivo imaging of the aortic specimens was performed. Biodistribution of radiolabelled c-myc ASON was evaluated in vivo in atherosclerotic rabbits.
RESULTS: Planar imaging revealed accumulation of (99m)Tc-labelled c-myc ASON in atherosclerotic lesions along the artery wall. Ex vivo imaging further demonstrated that the area of activity accumulation matched the area of atherosclerotic lesions. In contrast, no atherosclerotic lesions were found in the vessel wall and no positive imaging results were obtained in animals of the control group.
CONCLUSION: This molecular imaging approach has potential for non-invasive imaging of atherosclerotic plaques at an early stage.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15605287     DOI: 10.1007/s00259-004-1700-0

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  31 in total

Review 1.  Apoptosis in the cardiovascular system.

Authors:  Martin R Bennett
Journal:  Heart       Date:  2002-05       Impact factor: 5.994

2.  Imaging of thrombi with tissue-type plasminogen activator rendered enzymatically inactive and conjugated to a residualizing label.

Authors:  J M Ord; J Hasapes; A Daugherty; S R Thorpe; S R Bergmann; B E Sobel
Journal:  Circulation       Date:  1992-01       Impact factor: 29.690

3.  Morphologic and temporal analysis of vascular smooth muscle cell apoptosis induced by c-myc and E1A.

Authors:  R T Allen; W J Hunter; D K Agrawal
Journal:  Scanning       Date:  1998-11       Impact factor: 1.932

4.  Residence time of low-density lipoprotein in the normal and atherosclerotic rabbit aorta.

Authors:  E C Tozer; T E Carew
Journal:  Circ Res       Date:  1997-02       Impact factor: 17.367

5.  Indium-111-labeled platelet scintigraphy in carotid atherosclerosis.

Authors:  E Minar; H Ehringer; R Dudczak; R Schöfl; M Jung; R Koppensteiner; R Ahmadi; G Kretschmer
Journal:  Stroke       Date:  1989-01       Impact factor: 7.914

Review 6.  Insights into the pathophysiology of unstable coronary artery disease.

Authors:  S D Kristensen; H B Ravn; E Falk
Journal:  Am J Cardiol       Date:  1997-09-04       Impact factor: 2.778

Review 7.  Molecular signal transduction in vascular cell apoptosis.

Authors:  Y J Geng
Journal:  Cell Res       Date:  2001-12       Impact factor: 25.617

8.  Cultured human atherosclerotic plaque smooth muscle cells retain transforming potential and display enhanced expression of the myc protooncogene.

Authors:  J L Parkes; R R Cardell; F C Hubbard; D Hubbard; A Meltzer; A Penn
Journal:  Am J Pathol       Date:  1991-03       Impact factor: 4.307

9.  Noninvasive imaging of c-myc oncogene messenger RNA with indium-111-antisense probes in a mammary tumor-bearing mouse model.

Authors:  M K Dewanjee; A K Ghafouripour; M Kapadvanjwala; S Dewanjee; A N Serafini; D M Lopez; G N Sfakianakis
Journal:  J Nucl Med       Date:  1994-06       Impact factor: 10.057

Review 10.  Labelled oligonucleotides as radiopharmaceuticals: pitfalls, problems and perspectives.

Authors:  Cheraz Khélifi Younes; Raphaël Boisgard; Bertrand Tavitian
Journal:  Curr Pharm Des       Date:  2002       Impact factor: 3.116

View more
  6 in total

1.  Imaging of pre-mRNA splicing in living subjects using a genetically encoded luciferase reporter.

Authors:  Yaru Shi; Wei Liu; Haifeng Zheng; Zhiqiang Li; Xiaorui Shi; Shixuan Cai; Zhiqiang Jiao; Wenjie Mao; Jinrong Xie; Jie Tian; Fu Wang
Journal:  Biomed Opt Express       Date:  2018-01-08       Impact factor: 3.732

2.  Comparison of 99mTc-annexin A5 with 18F-FDG for the detection of atherosclerosis in ApoE-/- mice.

Authors:  Yan Zhao; Yuji Kuge; Songji Zhao; Koichi Morita; Masayuki Inubushi; H William Strauss; Francis G Blankenberg; Nagara Tamaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-04-17       Impact factor: 9.236

3.  99mTc-interleukin-2 scintigraphy for the in vivo imaging of vulnerable atherosclerotic plaques.

Authors:  Alessio Annovazzi; Elena Bonanno; Marcello Arca; Calogero D'Alessandria; Antonella Marcoccia; Luigi G Spagnoli; Francesco Violi; Francesco Scopinaro; Giorgio De Toma; Alberto Signore
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-10-12       Impact factor: 9.236

Review 4.  Pre-clinical and clinical evaluation of nuclear tracers for the molecular imaging of vulnerable atherosclerosis: an overview.

Authors:  L M Riou; A Broisat; J Dimastromatteo; G Pons; D Fagret; C Ghezzi
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

Review 5.  Atherosclerosis imaging on the molecular level.

Authors:  Frank M Bengel
Journal:  J Nucl Cardiol       Date:  2006 Jan-Feb       Impact factor: 5.952

6.  Rational Design of an Activatable Reporter for Quantitative Imaging of RNA Aberrant Splicing In Vivo.

Authors:  Jinrong Xie; Haifeng Zheng; Si Chen; Xiaorui Shi; Wenjie Mao; Fu Wang
Journal:  Mol Ther Methods Clin Dev       Date:  2020-04-18       Impact factor: 6.698

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.